Does CRISABOROLE Cause Neoplasm malignant? 9 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Neoplasm malignant have been filed in association with CRISABOROLE (Eucrisa). This represents 0.1% of all adverse event reports for CRISABOROLE.
9
Reports of Neoplasm malignant with CRISABOROLE
0.1%
of all CRISABOROLE reports
1
Deaths
0
Hospitalizations
How Dangerous Is Neoplasm malignant From CRISABOROLE?
Of the 9 reports, 1 (11.1%) resulted in death.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CRISABOROLE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does CRISABOROLE Cause?
Drug ineffective (1,815)
Application site pain (1,414)
Burning sensation (975)
Off label use (673)
Condition aggravated (613)
Pain (468)
Pruritus (378)
Rash (342)
Eczema (308)
Erythema (285)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which CRISABOROLE Alternatives Have Lower Neoplasm malignant Risk?
CRISABOROLE vs CRIZANLIZUMAB
CRISABOROLE vs CRIZANLIZUMAB-TMCA
CRISABOROLE vs CRIZOTINIB
CRISABOROLE vs CROFELEMER
CRISABOROLE vs CROMOLYN